Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_2
1
17%
Ph phase_1
2
33%
Ph phase_4
3
50%

Phase Distribution

2

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 21 (16.7%)
Phase 43 (50.0%)

Trials by Status

completed583%
withdrawn117%

Recent Activity

0 active trials
Showing 5 of 6
withdrawnphase_4

Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs

NCT00443963
completedphase_2

Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus

NCT00474903
completedphase_1

Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers

NCT01135472
completedphase_4

Barrett's Esophagus - 315 - 3 Way Cross-Over

NCT00637559
completedphase_4

Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

NCT00637845
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00443963Phase 4

Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs

Withdrawn
NCT00474903Phase 2

Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus

Completed
NCT01135472Phase 1

Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers

Completed
NCT00637559Phase 4

Barrett's Esophagus - 315 - 3 Way Cross-Over

Completed
NCT00637845Phase 4

Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

Completed
NCT00687245Phase 1

Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6